Bionime Corporation (4737.TW) TAI

54.20

-0.8(-1.45%)

Updated at June 03 01:30PM

Currency In TWD

Valuation

Market Cap4B
Enterprise Value6.64B
P/E Ratio-16.13
PEG Ratio0.25
Price/Sales Ratio2.38
Price/Book Ratio1.81
Enterprise/Revenue3.61
Enterprise/EBITDA-22.1

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.14
Operating Margin-0.16

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.13

Income Statement

Revenue1.84B
Revenue/Share24.01
Gross Profit627.81M
EBITDA-15.08M
Net Income-180.28M
Diluted EPS-2.65

Balance Sheet

Total Cash449.44M
Total Cash/Share6.12
Total Debt2.56B
Total Debt/Equity1.16
Current Ratio0.85
Book Value Per Share30.15

Price History

52-Week Change-20.68
52-Week High73.9
52-Week Low50.3
Moving Average 50 Days62.66
Moving Average 200 Days60.8

Statistics

Average Volume217,280
Shares Outstanding77.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1099:1000
Last Split DateSeptember 08, 2025